BridgeBio Pharma, Inc.
SEC Filing List
BBIO CIK: 0001743881
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 05/18/2026 | ||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| 8-K | Current report filing | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 05/13/2026 | |
| 4 | Statement of changes in beneficial owner... | Kumar Neil | goodwin procter llp /fa | 05/11/2026 | |
| S-3ASR | Automatic shelf registration statement o... | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 05/08/2026 | |
| 8-K | Current report filing | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 05/08/2026 | |
| 8-K | Current report filing | Bridgebio Pharma, Inc. | 05/07/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Bridgebio Pharma, Inc. | 05/07/2026 | ||
| 4 | Statement of changes in beneficial owner... | Apuli Maricel | goodwin procter llp /fa | 05/04/2026 | |
| ARS | Annual report to security holders | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| No record found. | |||||
| Load More | |||||
